Literature DB >> 6195179

Development of fluorescent-antibody reagents for demonstration of Pseudallescheria boydii in tissues.

J A Jackson, W Kaplan, L Kaufman, P Standard.   

Abstract

We prepared fluorescent-antibody reagents to detect and identify Pseudallescheria boydii in tissue. Antisera to broken mycelium and condidia (particulate antigens) and to culture filtrates (soluble antigens) of P. boydii were produced in rabbits. Antisera and globulin fractions of the antisera were labeled with fluorescein isothiocyanate and evaluated for their ability to stain P. boydii in tissues. The conjugates were first tested with cultures of 25 P. boydii isolates and 26 heterologous fungi that are morphologically similar to P. boydii in tissues. Labeled antibody to the soluble antigens reacted only weakly with cultures of P. boydii. Labeled antibody to particulate antigens brightly stained all P. boydii isolates and cross-reacted with Aspergillus flavus, Aspergillus fumigatus, Aspergillus nidulans, Aspergillus niger, Aspergillus terreus, Fusarium oxysporum, Fusarium solani, and a Scopulariopsis sp. The cross-reacting antibodies were removed by adsorption with A. fumigatus and F. oxysporum. The adsorbed conjugates stained P. boydii in Formalin-fixed tissues from experimentally infected mice and in Formalin-fixed tissues from humans and animals with natural infections. They did not stain the heterologous fungi in tissues.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6195179      PMCID: PMC270872          DOI: 10.1128/jcm.18.3.668-673.1983

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  25 in total

1.  A rare case of maduromycosis of the equine uterus.

Authors:  M M Reid; D R Jeffrey; G E Kaiser
Journal:  Vet Med Small Anim Clin       Date:  1976-07

2.  Demonstration of pathogenic fungi in formalin-fixed tissues by immunofluorescence.

Authors:  W Kaplan; D E Kraft
Journal:  Am J Clin Pathol       Date:  1969-10       Impact factor: 2.493

3.  Eumycotic mycetoma in a dog caused by Allescheria boydii.

Authors:  S S Jang; J A Popp
Journal:  J Am Vet Med Assoc       Date:  1970-10-15       Impact factor: 1.936

4.  A case of mycetoma with serological diagnosis of Allescheria boydii.

Authors:  M Baxter; I G Murray; J J Taylor
Journal:  Sabouraudia       Date:  1966-10

5.  Further studies on the diagnosis of mycetoma by double diffusion in agar.

Authors:  I G Murray; E S Mahgoub
Journal:  Sabouraudia       Date:  1968-02

6.  Allescheria boydii infection of the brain.

Authors:  L S Forno; M E Billingham
Journal:  J Pathol       Date:  1972-03       Impact factor: 7.996

7.  Keratitis due to Allescheria boydii (Monosporium apiospermum).

Authors:  J T Ernest; J W Rippon
Journal:  Am J Ophthalmol       Date:  1966-12       Impact factor: 5.258

8.  Maduromycosis (Allescheria boydii) in a dog.

Authors:  H J Kurtz; D R Finco; V Perman
Journal:  J Am Vet Med Assoc       Date:  1970-10-01       Impact factor: 1.936

9.  Mycologic, serologic and histologic findings in bovine abortion associated with Allescheria boydii.

Authors:  W U Knudtson; K Wohlgemuth; C A Kirkbride; M G Robl; M W Vorhies; J P McAdaragh
Journal:  Sabouraudia       Date:  1974-03

10.  Visceral fungal infections due to Petriellidium boydii (allescheria boydii). In vitro drug sensitivity studies.

Authors:  L I Lutwick; J N Galgiani; R H Johnson; D A Stevens
Journal:  Am J Med       Date:  1976-11       Impact factor: 4.965

View more
  3 in total

Review 1.  Developments in fungal taxonomy.

Authors:  J Guarro; A M Stchigel
Journal:  Clin Microbiol Rev       Date:  1999-07       Impact factor: 26.132

2.  Immunohistologic identification of Aspergillus spp. and other hyaline fungi by using polyclonal fluorescent antibodies.

Authors:  L Kaufman; P G Standard; M Jalbert; D E Kraft
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

Review 3.  Immunohistologic diagnosis of systemic mycoses: an update.

Authors:  L Kaufman
Journal:  Eur J Epidemiol       Date:  1992-05       Impact factor: 8.082

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.